688217.SH上海证券交易所 · 科创板 STAR
Shanghai Rightongene Biotechnology 睿昂基因
Medical Devices 医疗器械
¥25.65−¥0.14 · −0.54%
Open 开盘
¥25.80
High 最高
¥26.40
Low 最低
¥25.42
Prev Close 昨收
¥25.79
Volume 成交量
103.2万股
Turnover 成交额
¥2,662.2万
Mkt Cap 总市值
¥14亿
P/E 市盈率
−21.6×
Recent Activity 近期动态All Filings 全部公告 →
3 significant filings since 29 May 2026: 2 on change of interest and 1 on major holder selling. The latest, on 12 Aug 2026: 睿昂基因关于持股5%以上股东权益变动触及5%整数倍的提示性公告.
自 29 May 2026 起有 3 份重大公告：change of interest 2 份、major holder selling 1 份。最新一份（12 Aug 2026）：睿昂基因关于持股5%以上股东权益变动触及5%整数倍的提示性公告。
20.0022.5025.0027.5030.0032.50
Volume 成交量
286.5万
Sep 25Dec 25Mar 26Jun 26Sep 26
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Relative Value 同业比较
Medical Devices 医疗器械 · 140 listed peers
| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥14亿 | ¥47亿 | 8th lowest of 140 · 140 家中第 8 低 | |
| Trailing P/E 市盈率 | — | 40.4x | No value 无数据 | |
| P/B 市净率 | 1.7x | 2.4x | 37th lowest of 140 · 140 家中第 37 低 | |
| Revenue Growth 营收增速 | -20.4% | 4.0% | 6th lowest of 140 · 140 家中第 6 低 | |
| Profit Growth 净利增速 | -447.2% | -2.6% | 4th lowest of 140 · 140 家中第 4 低 | |
| Gross Margin 毛利率 | 77.4% | 55.2% | 9th highest of 140 · 140 家中第 9 高 | |
| Net Margin 净利率 | -22.1% | 10.7% | 10th lowest of 140 · 140 家中第 10 低 | |
| Return on Equity 净资产收益率 | -1.5% | 2.4% | 24th lowest of 140 · 140 家中第 24 低 | |
| Debt to Assets 资产负债率 | 3.9% | 19.2% | 2nd lowest of 140 · 140 家中第 2 低 | |
| Grade Score 评级得分 | 40 | 52 | 38th lowest of 140 · 140 家中第 38 低 |
Statement figures are for the period to 30 Jun 2026, filed by 140 of 140 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，140 家同业中 140 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
Largest Peers 主要同业
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics 迈瑞医疗 | ¥1,864亿 | 23.7x | 4.6x | 6.0% | 28.4% | 12.0% | C |
| Shanghai United Imaging Healthcare 联影医疗 | ¥844亿 | 47.7x | 3.8x | 17.2% | 12.6% | 4.1% | D |
| Shenzhen New Industries Biomedical 新产业 | ¥375亿 | 21.8x | 4.2x | 10.8% | 35.9% | 9.3% | B |
| APT Medical 惠泰医疗 | ¥334亿 | 35.8x | 10.8x | 25.7% | 34.6% | 16.0% | B |
| Wantai Biological 万泰生物 | ¥334亿 | — | 2.8x | 24.3% | -12.6% | -1.1% | D |
| Intco Medical Technology 英科医疗 | ¥322亿 | 28.3x | 1.7x | 40.6% | 13.1% | 4.5% | C |
| MGI Tech 华大智造 | ¥312亿 | — | 4.4x | 18.9% | -11.6% | -2.2% | D |
| Andon Health 九安医疗 | ¥288亿 | 6.5x | 1.2x | -30.6% | 578.7% | 13.7% | C |
| IRAY Group 奕瑞科技 | ¥279亿 | 38.7x | 3.6x | 56.7% | 25.0% | 6.4% | C |
| Jiangsu Yuyue Medical Equipment & Supply 鱼跃医疗 | ¥262亿 | 23.4x | 2.0x | -1.9% | 18.6% | 6.2% | C |
| Weigao Blood Purification 威高血净 | ¥216亿 | 44.0x | 1.8x | -0.4% | 13.1% | 3.2% | D |
| Lepu Medical Technology 乐普医疗 | ¥210亿 | 27.3x | 1.3x | -4.6% | 14.2% | 3.0% | D |
| Zhende Medical 振德医疗 | ¥207亿 | 74.8x | 3.6x | 5.9% | 6.8% | 2.5% | D |
| Autobio 安图生物 | ¥192亿 | 19.3x | 2.2x | -0.1% | 24.4% | 5.5% | C |
| Shanghai Rightongene Biotechnology 睿昂基因 | ¥14亿 | — | 1.7x | -20.4% | -22.1% | -1.5% | D |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。